Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 6/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | JAK1 | P23458 | 1/20 | 0.38 |
| ▸ | LIPC | P11150 | 1/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 4/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13566025 | 1.00 | CRHR1 (0.41) | CRHR1EPHX2JAK2JAK1LIPC | |
| SCHEMBL11935326 | 0.90 | CRHR1 (0.43) | CRHR1EPHX2JAK2JAK1LIPC | |
| SCHEMBL11936150 | 0.90 | CRHR1 (0.43) | CRHR1EPHX2JAK2JAK1LIPC | |
| SCHEMBL13439006 | 0.83 | CRHR1 (0.46) | CRHR1EPHX2JAK2JAK1LIPC | |
| SCHEMBL11935317 | 0.83 | CRHR1 (0.46) | CRHR1EPHX2JAK2JAK1LIPC | |
| SCHEMBL13565534 | 0.82 | MAPT (0.41) | CRHR1CNR2 | |
| SCHEMBL11936189 | 0.81 | NPY5R (0.49) | CRHR1EPHX2JAK2JAK1LIPC | |
| SCHEMBL11935441 | 0.81 | CRHR1 (0.42) | CRHR1EPHX2JAK2JAK1LIPC | |
| SCHEMBL13439177 | 0.81 | CRHR1 (0.42) | CRHR1EPHX2JAK2JAK1LIPC | |
| SCHEMBL10114859 | 0.80 | NPSR1 (0.50) | EPHX2NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9139518-B2 | Amine derivative having NPY Y5 receptor antagonistic activity | SHIONOGI & CO., LTD. (JP) | 2015-09-22 | — | — | US | disclosed |